Results 61 to 70 of about 1,020 (190)

Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study

open access: yesBMC Family Practice, 2020
Background Collaborative care approaches between general practitioners (GPs) and pharmacists have received international recognition for medication optimization and deprescribing efforts.
Navina Gerlach   +6 more
doaj   +1 more source

Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review. [PDF]

open access: yes, 2022
OBJECTIVE To synthesise the current knowledge on barriers and facilitators to deprescribing cardiovascular medications (CVMs) at the levels of patients, informal caregivers and healthcare providers (HCPs).
Aubert, Carole Elodie   +2 more
core   +1 more source

Attitudes, Beliefs and Perceptions of Medication Prescribing for Older First Nations Peoples: A Scoping Review

open access: yesAustralasian Journal on Ageing, Volume 45, Issue 2, June 2026.
ABSTRACT Objective To explore what is known about the attitudes, beliefs and perceptions of appropriate prescribing from the view of older First Nations Peoples (aged 45 years or older, residing in the community or residential care), substitute decision‐makers and health‐care professionals working with First Nations Peoples.
Nicola Franks   +5 more
wiley   +1 more source

Dataset on cost-analysis of medication deprescribing scenarios for older adult coverage under public drug benefit programs in Canada

open access: yesData in Brief, 2020
The dataset covers the equations and procedure used for the estimation of an older adult's total annual medication costs, across Canadian provinces and territories; detailed to report pharmacy margin, government share, and patient share.
Sarah Abu Fadaleh   +4 more
doaj   +1 more source

Deprescription: a global need to rationalize drug prescribing

open access: yesInternational Journal of Basic & Clinical Pharmacology, 2020
Appropriate prescribing and deprescription of unwanted medicines are a global concern. Polypharmacy is common in old age due to multiple comorbidities. This poses many risks that can be prevented by deprescription as a measure of planned reduction in number of medicines no longer needed.
Subhash Vishal   +2 more
openaire   +2 more sources

Examining HbA1c in Frail Older Adults: A Linked Data Cohort Study

open access: yesAustralasian Journal on Ageing, Volume 45, Issue 2, June 2026.
ABSTRACT Objective Diabetes and frailty pose a significant issue for society. Previous research has shown a mixed relationship between diabetes and frailty in older people, indicating a complex interrelationship. The aim of this study was to examine the association between routinely collected HbA1c testing data and frailty in a large cohort from ...
Gideon Meyerowitz‐Katz   +8 more
wiley   +1 more source

Understanding Medicine Preferences of Older Adults: The Role of Messaging in a Multi‐Methods Experimental Survey

open access: yesHealth Expectations
Background Efforts to optimise medicine use often focus on starting evidence‐based therapies or deprescribing inappropriate medicine, but not on the combination of both. We explored whether behavioural science‐informed messaging could impact older adults'
Alexander Chaitoff   +3 more
doaj   +1 more source

Realities of opioid and gabapentinoid deprescribing in socioeconomically disadvantaged communities: a qualitative evaluation

open access: yesBJGP Open
Background: Opioid and gabapentinoid prescribing has increased substantially in recent years despite having limited effectiveness in treating chronic primary pain.
Charlotte L Parbery-Clark   +2 more
doaj   +1 more source

Deprescription on oncological palliative care: an integrating review

open access: yesRevista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2020
Background: Patients on oncologic palliative care (OPC), due to diverse symptomatology and variable severity, tend to present polypharmacy that, although it seems justifiable in many cases, can pose health risks and negative consequences on patients’ quality of life.
Ana P. Antonio   +3 more
openaire   +3 more sources

La pharmacogénomique: perspectives et enjeux éthico-juridiques [PDF]

open access: yes, 2004
La pharmacogénomique est l’étude de la totalité des gènes impliqués dans les réactions aux médicaments. Cette nouvelle technique de développement des médicaments laisse entrevoir d’immenses possibilités, elle soulève également de nombreuses questions ...
Joly, Yann
core  

Home - About - Disclaimer - Privacy